V Wave develops an implant for the treatment of congestive heart failure.
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 16, 2021 | Series C | $98M | 1 | — | — | Detail |
Sep 22, 2020 | Series C | $28M | 1 | — | — | Detail |
Apr 27, 2018 | Series C | $70M | 1 | — | — | Detail |
Jan 11, 2016 | Series B | $28M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Triventures | — | Series C |